Top

Published in:

Open Access 01-12-2008 | Review

Centronuclear (myotubular) myopathy

Authors: Heinz Jungbluth, Carina Wallgren-Pettersson, Jocelyn Laporte

Published in: Orphanet Journal of Rare Diseases | Issue 1/2008

Abstract

Centronuclear myopathy (CNM) is an inherited neuromuscular disorder characterised by clinical features of a congenital myopathy and centrally placed nuclei on muscle biopsy.

The incidence of X-linked myotubular myopathy is estimated at 2/100000 male births but epidemiological data for other forms are not currently available.

The clinical picture is highly variable. The X-linked form usually gives rise to a severe phenotype in males presenting at birth with marked weakness and hypotonia, external ophthalmoplegia and respiratory failure. Signs of antenatal onset comprise reduced foetal movements, polyhydramnios and thinning of the ribs on chest radiographs; birth asphyxia may be the present. Affected infants are often macrosomic, with length above the 90^th centile and large head circumference. Testes are frequently undescended. Both autosomal-recessive (AR) and autosomal-dominant (AD) forms differ from the X-linked form regarding age at onset, severity, clinical characteristics and prognosis. In general, AD forms have a later onset and milder course than the X-linked form, and the AR form is intermediate in both respects.

Mutations in the myotubularin (MTM1) gene on chromosome Xq28 have been identified in the majority of patients with the X-linked recessive form, whilst AD and AR forms have been associated with mutations in the dynamin 2 (DNM2) gene on chromosome 19p13.2 and the amphiphysin 2 (BIN1) gene on chromosome 2q14, respectively. Single cases with features of CNM have been associated with mutations in the skeletal muscle ryanodine receptor (RYR1) and the hJUMPY (MTMR14) genes.

Diagnosis is based on typical histopathological findings on muscle biopsy in combination with suggestive clinical features; muscle magnetic resonance imaging may complement clinical assessment and inform genetic testing in cases with equivocal features. Genetic counselling should be offered to all patients and families in whom a diagnosis of CNM has been made.

The main differential diagnoses include congenital myotonic dystrophy and other conditions with severe neonatal hypotonia.

Management of CNM is mainly supportive, based on a multidisciplinary approach. Whereas the X-linked form due to MTM1 mutations is often fatal in infancy, dominant forms due to DNM2 mutations and some cases of the recessive BIN1-related form appear to be associated with an overall more favourable prognosis.

Available only for authorised users

McKusick VA: Mendelian Inheritance in Man. A Catalog of Human Genes and Genetic Disorders. 1998, Baltimore, London: The Johns Hopkins University Press, 12

Spiro AJ, Shy GM, Gonatas NK: Myotubular myopathy. Archives of Neurology. 1966, 14: 1-14.PubMed

Wallgren-Pettersson C: Congenital nemaline myopathy: a longitudinal study. J Neurol Sci. 1989, University of Helsinki, Commentationes Physico-Mathematicae1990 111/1990, 89 (1): 1-14. 10.1016/0022-510X(89)90002-6. Dissertationes 30: 102

Hughes MI, Hicks EM, Nevin NC, Patterson VH: The prevalence of inherited neuromuscular disease in Northern Ireland. Neuromuscul Disord. 1996, 6: 69-73. 10.1016/0960-8966(94)00017-4.PubMed

Darin N, Tulinius M: Neuromuscular disorders in childhood: a descriptive epidemiological study from Western Sweden. Neuromuscul Disord. 2000, 10: 1-9. 10.1016/S0960-8966(99)00055-3.PubMed

van Wijngaarden GK, Fleury P, Bethlem J, Meijer H: Familial "myotubular" myopathy. Neurology. 1969, 19: 901-908.PubMed

Meyers KR, Golomb HM, Hansen JL, McKusick VA: Familial neuromuscular disease with "myotubes.". Clin Genet. 1974, 5: 327-337.PubMed

Barth PG, van Wijngaarden GK, Bethlem J: X-linked myotubular myopathy with fatal neonatal asphyxia. Neurology. 1975, 25: 531-536.PubMed

Ambler MW, Neave C, Tutschka BG, Pueschel SM, Orson JM, Singer DB: X-linked recessive myotubular myopathy. I. Clinical and pathologic findings in a family. Hum Pathol. 1984, 15: 566-574. 10.1016/S0046-8177(84)80011-8.PubMed

10.

Heckmatt JZ, Sewry CA, Hodes D, Dubowitz V: Congenital centronuclear (myotubular) myopathy: a clinical, pathological and genetic study in eight children. Brain. 1985, 108: 941-964. 10.1093/brain/108.4.941.PubMed

11.

Keppen LD, Husain MM, Woody RC: X-linked myotubular myopathy: intrafamilial variability and normal muscle biopsy in a heterozygous female. Clin Genet. 1987, 32: 95-99.PubMed

12.

Oldfors A, Kyllerman M, Wahlström J, Darnfors C, Henriksson KG: X-linked myotubular myopathy: clinical and pathological findings in a family. Clin Genet. 1989, 36: 5-14.PubMed

13.

Braga SE, Gerber A, Meier C, Weiersmueller A, Zimmermann A, Herrmann U, Liechti S, Moser H: Severe neonatal asphyxia due to X-linked centronuclear myopathy. Eur J Pediatr. 1990, 150: 132-135. 10.1007/BF02072056.PubMed

14.

Lo WD, Barohn RJ, Bobulski RJ, Bobulski , Kean J, Mendell JR: Centronuclear myopathy and type 1 hypotrophy without central nuclei. Distinct nososlogic entities?. Arch Neurol. 1990, 47: 273-276.PubMed

15.

Breningstall GN, Grover WD, Marks HG: Maternal muscle biopsy in X-linked recessive centronuclear (myotubular) myopathy. Am J Med Genet. 1991, 39 (1): 13-18. 10.1002/ajmg.1320390105.PubMed

16.

Tyson RW, Ringel SP, Manchester DK, Shikes RH, Goodman SI: X-linked myotubular myopathy: a case report of prenatal and perinatal aspects. Pediatr Pathol. 1992, 12: 535-543. 10.3109/15513819209024203.PubMed

17.

Wallgren-Pettersson C, Thomas N: Report on the 20th ENMC sponsored international workshop: myotubular/centronuclear myopathy. Neuromuscul Disord. 1994, 4: 71-74. 10.1016/0960-8966(94)90050-7.PubMed

18.

Wallgren-Pettersson C, Clarke A, Samson F, Fardeau M, Dubowitz V, Moser H, Grimm T, Barohn RJ, Barth PG: The myotubular myopathies: differential diagnosis of the X-linked recessive, autosomal dominant and autosomal recessive forms and present state of DNA studies. J Med Genet. 1995, 32: 673-679.PubMedCentralPubMed

19.

McEntagart M, Parsons G, Buj-Bello A, Biancalana V, Fenton I, Little M, Krawczak M, Thomas N, Herman G, Clarke A, Wallgren-Pettersson C: Genotype-phenotype correlations in X-linked myotubular myopathy. Neuromuscul Disord. 2002, 12: 939-946. 10.1016/S0960-8966(02)00153-0.PubMed

20.

Osborne JP, Murphy EG, Hill A: Thin ribs on chest X-ray: a useful sign in the differential diagnosis of the floppy newborn. Dev Med Child Neurol. 1983, 25: 343-345.PubMed

21.

Teeuw AH, Barth PG, van Sonderen L, Zondervan HA: 3 examples of fetal genetic neuromuscular disorders which lead to hydramnion. Ned Tijdschr Geneeskd. 1993, 137: 908-913.PubMed

22.

Barth PG, Dubowitz V: X-linked myotubular myopathy – A long-term follow up study. Eur J Ped Neurol. 1998, 1: 49-56. 10.1016/1090-3798(98)01004-9.

23.

LeGuennec J-C, Bernier J-P, Lamarche J: High stature in neonatal myotubular myopathy. Acta Paediatr Scand. 1988, 77: 610-611. 10.1111/j.1651-2227.1988.tb10714.x.PubMed

24.

Joseph M, Pai GS, Holden KR, Herman G: X-linked myotubular myopathy: clinical observations in ten additional cases. Am J Med Genet. 1995, 59: 168-173. 10.1002/ajmg.1320590211.PubMed

25.

Sarnat HB, Roth SI, Jimenez JF: Neonatal myotubular myopathy: neuropathy and failure of postnatal maturation of fetal muscle. Can J Neurol Sci. 1981, 8: 313-320.PubMed

26.

Herman GE, Finegold M, Zhao W, de Gouyon B, Metzenberg A: Medical complications in long-term survivors with X-linked myotubular myopathy. J Pediatr. 1999, 134: 206-214. 10.1016/S0022-3476(99)70417-8.PubMed

27.

Yu S, Manson J, White S, Bourne A, Waddy H, Davis M, Haan E: X-linked myotubular myopathy in a family with three adult survivors. Clin Genet. 2003, 64: 148-152. 10.1034/j.1399-0004.2003.00118.x.PubMed

28.

Biancalana V, Caron O, Gallati S, Baas F, Kress W, Novelli G, Dàpice MR, Lagier-Tourenne C, Buj-Bello A, Romero NB, Mandel JL: Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum Genet. 2003, 112: 135-142.PubMed

29.

Chanzy S, Routon MC, Moretti S, de Gennes C, Mselati JC: Unusual good prognosis for X-linked myotubular myopathy. Arch Pediatr. 2003, 10: 707-709. 10.1016/S0929-693X(03)00287-2.PubMed

30.

Hu LJ, Laporte J, Kress W, Kioschis P, Siebenhaar R, Poustka A, Fardeau M, Metzenberg A, Janssen EA, Thomas N, Mandel JL, Dahl N: Deletions in Xq28 in two boys with myotubular myopathy and abnormal genital development define a new contiguous gene syndrome in a 430 kb region. Hum Mol Genet. 1999, 5: 139-143. 10.1093/hmg/5.1.139.

31.

Fukami M, Wada Y, Miyabayashi K, Nishino I, Hasegawa T, Nordenskjöld A, Camerino G, Kretz C, Buj-Bello A, Laporte J, Yamada G, Morohashi K, Ogata T: CXorf6 is a causative gene for hypospadias. Nat Genet. 2006, 38 (12): 1369-1371. 10.1038/ng1900.PubMed

32.

Sawchak JA, Sher JH, Norman MG, Kula RW, Shafiq SA: Centronuclear myopathy heterogeneity: distinction of clinical types by myosin isoform patterns. Neurology. 1991, 41: 135-140.PubMed

33.

Hammans SR, Robinson DO, Moutou C, Kennedy CR, Dennis NR, Hughes PJ, Ellison DW: A clinical and genetic study of a manifesting heterozygote with X-linked myotubular myopathy. Neuromuscul Disord. 2000, 10: 133-137. 10.1016/S0960-8966(99)00073-5.PubMed

34.

Wallgren-Pettersson C: Report of the 72nd ENMC International Workshop on Myotubular Myopathy, Hilversum, The Netherlands, 1–3 October 1999. Neuromuscul Disord. 2000, 10: 521-525.

35.

Tanner SM, Orstavik KH, Kristiansen M, Lev D, Lerman-Sagie T, Sadeh M, Liechti-Gallati S: Skewed X-inactivation in a manifesting carrier of X-linked myotubular myopathy and in her non-manifesting carrier mother. Hum Genet. 1999, 104: 249-253. 10.1007/s004390050943.PubMed

36.

Sutton IJ, Winer JB, Norman AN, Liechti-Gallati S, MacDonald F: Limb girdle and facial weakness in female carriers of X-linked myotubular myopathy mutations. Neurology. 2001, 57: 900-902.PubMed

37.

Jungbluth H, Sewry CA, Buj-Bello A, Kristiansen M, Orstavik KH, Kelsey A, Manzur AY, Mercuri E, Wallgren-Pettersson C, Muntoni F: Early and severe presentation of X-linked myotubular myopathy in a girl with skewed X-inactivation. Neuromuscul Disord. 2003, 13: 55-59. 10.1016/S0960-8966(02)00194-3.PubMed

38.

Schara U, Kress W, Tucke J, Mortier W: X-linked myotubular myopathy in a female infant caused by a new MTM1 gene mutation. Neurology. 2003, 60: 1363-1365. 10.1001/archneur.60.10.1363.PubMed

39.

Kristiansen M, Knudsen GP, Tanner SM, McEntagart M, Jungbluth H, Muntoni F, Sewry C, Gallati S, Orstavik KH, Wallgren-Pettersson C: X-inactivation patterns in carriers of X-linked myotubular myopathy. Neuromuscul Disord. 2003, 13: 468-471. 10.1016/S0960-8966(03)00067-1.PubMed

40.

Dahl N, Hu LJ, Chery M, Fardeau M, Gilgenkrantz S, Nivelon-Chevallier , Sidaner-Noisette I, Mugneret F, Gouyon JB, Gal A: Myotubular myopathy in a girl with a deletion at Xq27-q28 and unbalanced X-inactivation assigns the MTM1 gene to a 600-kb region. Am J Hum Genet. 1995, 56: 1108-1115.PubMedCentralPubMed

41.

De Angelis MS, Palmucci L, Leone M, Doriguzzi C: Centronuclear myopathy: clinical, morphological and genetic characters. A review of 288 cases. J Neurol Sci. 1991, 103: 2-9. 10.1016/0022-510X(91)90275-C.PubMed

42.

Sher JH, Rimalovski AB, Athanassiades TJ, Aronson SM: Familial centronuclear myopathy: a clinical and pathological study. Neurology. 1967, 17: 727-742.PubMed

43.

Radu H, Killyen I, Ionescu V, Radu A: Myotubular (centronuclear) (neuro-) myopathy. I. Clinical, genetical and morphological studies. Eur Neurol. 1977, 15: 285-300. 10.1159/000114815.PubMed

44.

Verhiest W, Brucher JM, Goddeeris P, Lauweryns J, De Geest H: Familial centronuclear myopathy associated with "cardiomyopathy.". Br Heart J. 1976, 38: 504-509. 10.1136/hrt.38.5.504.PubMedCentralPubMed

45.

Serratrice G, Pellissier JF, Faugére MC, Gastaut JL: Centronuclear myopathy: possible central nervous system origin. Muscle Nerve. 1978, 1: 62-69. 10.1002/mus.880010109.PubMed

46.

Pavone L, Mollica F, Grasso A, Pero G: Familial centronuclear myopathy. Acta Neurol Scand. 1980, 62: 33-40.PubMed

47.

Fitzsimons RB, McLeod JG: Myopathy with pathological features of both centronuclear myopathy and multicore disease. J Neurol Sci. 1982, 57: 395-405. 10.1016/0022-510X(82)90044-2.PubMed

48.

Martin JJ: On some myopathies with oculomotor involvement. Acta Neurol Belg. 1987, 87: 207-228.PubMed

49.

Müller B, Mostacciuolo ML, Danieli GA, Grimm T: Problems in genetic counseling in a family with "atypical" centronuclear myopathy. Am J Med Genet. 1989, 32: 417-419. 10.1002/ajmg.1320320330.PubMed

50.

Jeannet PY, Bassez G, Eymard B, Laforêt P, Urtizberea JA, Rouche A, Guicheney P, Fardeau M, Romero NB: Clinical and histologic findings in autosomal centronuclear myopathy. Neurology. 2004, 62 (9): 1484-1490.PubMed

51.

Moosa A, Dawood AA: Centronuclear myopathy in black African children–report of 4 cases. Neuropediatrics. 1987, 18: 213-217.PubMed

52.

Zanoteli E, Oliveira AS, Kiyomoto BH, Schmidt B, Gabbai AA: Histopathological aspects in ten patients with childhood onset. Arq Neuropsiquiatr. 1998, 56: 1-8.PubMed

53.

Zanoteli E, Guimaraes AS, Martins RJ, Yamashita HK, Toledo CS, Oliveira AS, Gabbai AA: Temporomandibular joint involvement in a patient with centronuclear myopathy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000, 90: 118-121. 10.1067/moe.2000.107051.PubMed

54.

Siegel M: Foot deformity in myotubular myopathy. Pathology of intrinsic foot musculature. Arch Neurol. 1983, 40: 589-PubMed

55.

Pages M, Cesari JB, Pages AM: Centronuclear myopathy. Complete review of the literature apropos of a case. Ann Pathol. 1982, 2: 301-310.PubMed

56.

Gospe SM, Armstrong DL, Gresik MV, Hawkins HK: Life-threatening congestive heart failure as the presentation of centronuclear myopathy. Pediatr Neurol. 1987, 3: 117-120. 10.1016/0887-8994(87)90040-3.PubMed

57.

Bataille J, Guillon F, Urtizberea A, Estournet B, Richard S, Barois A: Pathological anatomy of the heart in myopathies and infantile muscular atrophies. Ann Med Interne (Paris). 1991, 142: 5-8.

58.

Alonso JL, Cavaliere MJ, Gagioti SM, Atalla AA, Nascimento I, Dias JC: Myotubular myopathy: clinical, electrophysiological and histological study of a case. Arq Neuropsiquiatr. 1981, 39: 450-472.PubMed

59.

Nicot AS, Toussaint A, Tosch V, Kretz C, Wallgren-Pettersson C, Iwarsson E, Kingston H, Garnier JM, Biancalana V, Oldfors A, Mandel JL, Laporte J: Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet. 2007, 39 (9): 1134-1139. 10.1038/ng2086.PubMed

60.

Muller AJ, Baker JF, DuHadaway JB, Ge K, Farmer G, Donover PS, Meade R, Reid C, Grzanna R, Roach AH, Shah N, Soler AP, Prendergast GC: Targeted disruption of the murine Bin1/Amphiphysin II gene does not disable endocytosis but results in embryonic cardiomyopathy with aberrant myofibril formation. Mol Cell Biol. 2003, 23 (12): 4295-4306. 10.1128/MCB.23.12.4295-4306.2003.PubMedCentralPubMed

61.

Reske-Nielsen E, Hein-Sørensen O, Vorre P: Familial centronuclear myopathy: a clinical and pathological study. Acta Neurol Scand. 1987, 76: 115-122.PubMed

62.

Ferrer X, Vital C, Coquet M, Deleplanque B, Ellie E, Lagueny A, Julien J: Myopathie centronucléaire autosomique dominante. Rev Neurol (Paris). 1992, 148: 622-630.

63.

Cartier L, Hernandez JE: [Late centronuclear myopathy: autosomal dominant form]. Revista Medica de Chile. 1996, 124: 209-216.PubMed

64.

Edström L, Wroblewski R, Mair WGP: Genuine myotubular myopathy. Muscle Nerve. 1982, 5: 604-613. 10.1002/mus.880050804.PubMed

65.

Isaacs H, Badenhorst ME: Centronuclear myopathy–an inherited neuromuscular disorder. A report of 3 cases. S Afr Med J. 1991, 80: 247-250.PubMed

66.

Karpati G, Carpenter S, Nelson RF: Type I muscle fiber atrophy and central nuclei. A rare familial neuromuscular disease. J Neurol Sci. 1970, 10: 489-500. 10.1016/0022-510X(70)90027-4.PubMed

67.

McLeod JG, Baker WDEC, Lethlean AK, Shorey CD: Centronuclear myopathy with autosomal dominant inheritance. J Neurol Sci. 1972, 15: 375-387. 10.1016/0022-510X(72)90166-9.PubMed

68.

Schochet SS, Zellweger H, Ionasescu V, McCormick WF: Centronuclear myopathy: disease entity or syndrome? Light- and electron microscopic study of two cases and review of the literature. J Neurol Sci. 1972, 16: 215-228. 10.1016/0022-510X(72)90091-3.PubMed

69.

Kinoshita M, Satoyoshi E, Matsuo N: "Myotubular myopathy" and "type I fiber atrophy" in a family. J Neurol Sci. 1975, 26: 575-582. 10.1016/0022-510X(75)90058-1.PubMed

70.

Mortier W, Michaelis E, Becker J, Gerhard L: Centronucleäre Myopathie mit autosomal dominanten Erbgang. Humangenetik. 1975, 27: 199-215. 10.1007/BF00278346.PubMed

71.

Pépin B, Mikol J, Goldstein B, Haguenau M, Godlewski S: Forme familiale de myopathie centronucleaire de l'adulte. Rev Neurol (Paris). 1976, 132: 845-857.

72.

Bill P, Cole G, Proctor NSF, Saffer D, Botes A: Crural hypertrophy associated with centronuclear myopathy. J Neurol Neurosurg Psychiat. 1979, 42: 542-547.PubMedCentralPubMed

73.

Torres CF, Griggs RC, Goetz JP: Severe neonatal centronuclear myopathy with autosomal dominant inheritance. Arch Neurol. 1985, 42: 1011-1014.PubMed

74.

Lovaste MG, Aldovini D, Ferrari G: Centronuclear myopathy with unusual clinical picture. Eur Neurol. 1987, 26: 153-160. 10.1159/000116328.PubMed

75.

Felice KJ, Grunnet ML: Autosomal dominant centronuclear myopathy: report of a new family with clinical features simulating facioscapulohumeral syndrome. Muscle Nerve. 1997, 20: 1194-1196. 10.1002/(SICI)1097-4598(199709)20:9<1194::AID-MUS19>3.0.CO;2-T.PubMed

76.

Bitoun M, Maugenre S, Jeannet PY, Lacène E, Ferrer X, Laforêt P, Martin JJ, Laporte J, Lochmüller H, Beggs AH, Fardeau M, Eymard B, Romero NB, Guicheney P: Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet. 2005, 37 (11): 1207-1209. 10.1038/ng1657.PubMed

77.

Fischer D, Herasse M, Bitoun M, Barragan-Campos , Chiras J, Laforet P, Fardeau M, Eymard B, Guicheney P, Romero NB: Characterization of the muscle involvement in dynamin 2-relatedcentronuclear myopathy. Brain. 2006, 129: 1463-1469. 10.1093/brain/awl071.PubMed

78.

Schessl J, Medne L, Hu Y, Zou Y, Brown MJ, Huse JT, Torigian DA, Jungbluth H, Goebel HH, Bönnemann CG: MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement. Neuromuscul Disord. 2007, 17 (1): 28-32. 10.1016/j.nmd.2006.09.013.PubMed

79.

Echaniz-Laguna A, Nicot AS, Carré S, Franques J, Tranchant C, Dondaine N, Biancalana V, Mandel JL, Laporte J: Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation. Neuromuscul Disord. 2007, 17 (11–12): 955-959. 10.1016/j.nmd.2007.06.467.PubMed

80.

Züchner S, Noureddine M, Kennerson M, Verhoeven K, Claeys K, De Jonghe P, Merory J, Oliveira SA, Speer MC, Stenger JE, Walizada G, Zhu D, Pericak-Vance MA, Nicholson G, Timmerman V, Vance JM: Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet. 2005, 37 (3): 289-294. 10.1038/ng1514.PubMed

81.

Bitoun M, Bevilacqua JA, Prudhon B, Maugenre S, Taratuto AL, Monges S, Lubieniecki F, Cances C, Uro-Coste E, Mayer M, Fardeau M, Romero NB, Guicheney P: Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset. Ann Neurol. 2007, 62 (6): 666-670. 10.1002/ana.21235.PubMed

82.

Jungbluth H, Zhou H, Sewry CA, Robb S, Treves S, Bitoun M, Guicheney P, Buj-Bello A, Bönnemann C, Muntoni F: Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2007, 17 (4): 338-345. 10.1016/j.nmd.2007.01.016.PubMed

83.

Jungbluth H, Zhou H, Hartley L, Halliger-Keller B, Messina S, Longman C, Brockington M, Robb SA, Straub V, Voit T, Swash M, Ferreiro A, Bydder G, Sewry CA, Müller C, Muntoni F: Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology. 2005, 65 (12): 1930-1935. 10.1212/01.wnl.0000188870.37076.f2.PubMed

84.

Jungbluth H: Multi-minicore Disease. Orphanet J Rare Dis. 2007, 2: 3-10.1186/1750-1172-2-3.

85.

Quinn RD, Pae WE, McGary SA, Wickey GS: Development of malignant hyperthermia during mitral valve replacement. Ann Thorac Surg. 1992, 53: 1114-1116.PubMed

86.

Thomas NST, Sarfarazi M, Roberts K: X-linked myotubular myopathy (MTM1): evidence for linkage to Xq28 markers. Cytogenet Cell Genet. 1987, 46: (Abstr) 704.-

87.

Darnfors C, Larsson HE, Oldfors A, Kyllerman M, Gustavson KH, Bjursell G, Wahlstroem J: X-linked myotubular myopathy: a linkage study. Clin Genet. 1990, 37: 335-340.PubMed

88.

Lehesjoki A-E, Sankila E-M, Miao J, Somer M, Salonen R, Rapola J, de la Chapelle A: X-linked neonatal myotubular myopathy: one recombination detected with polymorphic DNA markers from Xq28. J Med Genet. 1990, 27: 288-291.PubMedCentralPubMed

89.

Starr J, Lamont M, Iselius J, Harvey J, Heckmatt J: A linkage study of a large pedigree with X-linked centronuclear myopathy. J Med Genet. 1990, 27: 281-283.PubMedCentralPubMed

90.

Thomas NST, Williams H, Cole G, Roberts K, Clarke A, Liechti-Gallati S, Braga S, Gerber A, Meier C, Moser H: X-linked neonatal centronuclear/myotubular myopathy: evidence for linkage to Xq28 DNA marker loci. J Med Genet. 1990, 27: 284-287.PubMedCentralPubMed

91.

Liechti-Gallati S, Müller B, Grimm T, Kress W, Mueller C, Boltshauser E, Moser H, Braga S: X-linked centronuclear myopathy: mapping the gene to Xq28. Neuromuscul Disord. 1991, 1: 239-245. 10.1016/0960-8966(91)90096-B.PubMed

92.

Dahl N, Samson F, Thomas NST, Hu LJ, Gong W, Herman G, Laporte J, Kioschis P, Poustka A, Mandel JL: X-linked myotubular myopathy (MTM1) mapped between DXS304 and DXS305, closely linked to the DXS455 VNTR and a new, highly informative microsatellite marker. J Med Genet. 1994, 31: 922-924.PubMedCentralPubMed

93.

Liechti-Gallati S, Wolff G, Uwe-Peter K, Braga S: Prenatal diagnosis of X-linked centronuclear myopathy by linkage analysis. Pediatr Res. 1993, 33: 201-204.PubMed

94.

Janssen EA, Hensels GW, van Oost BA, Hamel BC, Kemp S, Baas F, Weber JW, Barth PG, Bolhuis PA: The gene for X-linked myotubular myopathy is located in a 8 Mb region at the border of Xq27.3 and Xq28. Neuromuscul Disord. 1994, 4: 455-461. 10.1016/0960-8966(94)90084-1.PubMed

95.

Laporte J, Hu LJ, Kretz C, Mandel JL, Kioschis P, Coy JF, Klauck SM, Poustka A, Dahl N: A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nature Genet. 1996, 13: 175-182. 10.1038/ng0696-175.PubMed

96.

Laporte J, Guiraud-Chaumeil C, Vincent MC, Mandel JL, Tanner SM, Liechti-Gallati S, Wallgren-Pettersson C, Dahl N, Kress W, Bolhuis PA, Fardeau M, Samson F, Bertini E: Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC International Consortium on Myotubular Myopathy. European Neuro-Muscular Center. Hum Mol Genet. 1997, 6: 1505-1511. 10.1093/hmg/6.9.1505.PubMed

97.

Laporte J, Biancalana V, Tanner SM, Kress W, Schneider V, Wallgren-Pettersson , Herger F, Buj-Bello A, Blondeau F, Liechti-Gallati S, Mandel JL: MTM1 Mutations in X-linked myotubular myopathy. Hum Mutat. 2000, 15: 393-409. 10.1002/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R.PubMed

98.

Tanner SM, Schneider V, Thomas NS, Clarke A, Lazarou L, Liechti-Gallati S: Characterization of 34 novel and six known MTM1 gene mutations in 47 unrelated X-linked myotubular myopathy patients. Neuromuscul Disord. 1999, 9: 41-49. 10.1016/S0960-8966(98)00090-X.PubMed

99.

Herman GE, Kopacz K, Zhao W, Mills PL, Metzenberg A, Das S: Characterization of mutations in fifty North American patients with X-linked myotubular myopathy. Hum Mutat. 2002, 19: 114-121. 10.1002/humu.10033.PubMed

100.

Tsai TC, Horinouchi H, Noguchi S, Minami N, Murayama K, Hayashi YK, Nonaka I, Nishino I: Characterization of MTM1 mutations in 31 Japanese families with myotubular myopathy, including a patient carrying 240 kb deletion in Xq28 without male hypogenitalism. Neuromuscul Disord. 2005, 5 (3): 245-252. 10.1016/j.nmd.2004.12.005.

101.

Flex E, De Luca A, D'Apice MR, Buccino A, Dallapiccola B, Novelli G: Rapid scanning of myotubularin (MTM1) gene by denaturing high-performance liquid chromatography (DHPLC). Neuromuscul Disord. 2002, 12: 501-505. 10.1016/S0960-8966(01)00328-5.PubMed

102.

Bertini E, Biancalana V, Bolino A, Buj-Bello A, Clague M, Guicheney P, Jungbluth H, Kress W, Musaro A, Nandurkar N, Pirola L, Romero N, Senderek J, Suter U, Sewry C, Tronchere H, Wallgren-Pettersson C, Wishart MJ, Laporte J: 118^th ENMC International Workshop on Advances in Myotubular Myopathy. 26–28 September 2003, Naarden, The Netherlands. (5^th Workshop of the International Consortium on Myotubular Myopathy). Neuromuscul Disord. 2004, 14: 387-396. 10.1016/j.nmd.2004.04.002.PubMed

103.

De Gouyon BM, Zhao W, Laporte J, Mandel JL, Metzenberg A, Herman GE: Characterization of mutations in the myotubularin gene in twenty six patients with X-linked myotubular myopathy. Hum Mol Genet. 1997, 6: 1499-1504. 10.1093/hmg/6.9.1499.PubMed

104.

Nishino I, Minami N, Kobayashi O, Ikezawa M, Goto Y, Arahata K, Nonaka I: MTM1 gene mutations in Japanese patients with the severe infantile form of myotubular myopathy. Neuromuscul Disord. 1998, 8: 453-458. 10.1016/S0960-8966(98)00075-3.PubMed

105.

Donnelly A, Haan E, Manson J, Mulley J: A novel mutation in exon b (R259C) of the MTM1 gene is associated with a mild myotubular myopathy. Hum Mutat. 1998, 11 (4): 334-10.1002/(SICI)1098-1004(1998)11:4<334::AID-HUMU20>3.0.CO;2-#.PubMed

106.

Buj-Bello A, Biancalana V, Moutou C, Laporte J, Mandel JL: Identification of novel mutations in the MTM1 gene causing severe and mild forms of X-linked myotubular myopathy. Human Mutation. 1999, 14: 320-325. 10.1002/(SICI)1098-1004(199910)14:4<320::AID-HUMU7>3.0.CO;2-O.PubMed

107.

De Luca A, Torrente I, Mangino M, Bertini E, Dallapiccola B, Novelli G: A novel mutation (R27 1X) in the myotubularin gene causes a severe myotubular myopathy. Human Heredity. 1999, 49: 59-60. 10.1159/000022843.PubMed

108.

Vincent MC, Guiraud-Chaumeil C, Laporte J, Manouvrier-Hanu S, Mandel JL: Extensive germinal mosaicism in a family with X linked myotubular myopathy simulates genetic heterogeneity. J Med Genet. 1998, 35: 241-243.PubMedCentralPubMed

109.

Hane BG, Rogers RC, Schwartz CE: Germline mosaicism in X-linked myotubular myopathy. Clin Genet. 1999, 56: 77-81. 10.1034/j.1399-0004.1999.560111.x.PubMed

110.

Pierson CR, Agrawal PB, Blasko J, Beggs AH: Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy. Neuromuscul Disord. 2007, 17 (7): 562-568. 10.1016/j.nmd.2007.03.010.PubMedCentralPubMed

111.

Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MA, Georgiou DM, Christodoulou K, Hausmanowa-Petrusewicz I, Mandich P, Schenone A, Gambardella A, Bono F, Quattrone A, Devoto M, Monaco AP: Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet. 2000, 25: 17-19. 10.1038/75542.PubMed

112.

Berger P, Schaffitzel C, Berger I, Ban N, Suter U: Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module. Proc Natl Acad Sci USA. 2003, 100 (21): 12177-12182. 10.1073/pnas.2132732100.PubMedCentralPubMed

113.

Azzedine H, Bolino A, Taïeb T, Birouk N, Di Duca M, Bouhouche A, Benamou S, Mrabet A, Hammadouche T, Chkili T, Gouider R, Ravazzolo R, Brice A, Laporte J, LeGuern E: Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am J Hum Genet. 2003, 72: 1141-1153. 10.1086/375034.PubMedCentralPubMed

114.

Senderek J, Bergmann C, Weber S, Ketelsen UP, Schorle H, Rudnik-Schoneborn S, Buettner R, Buchheim E, Zerres K: Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet. 2003, 12: 349-356. 10.1093/hmg/ddg030.PubMed

115.

Laporte J, Blondeau F, Buj-Bello A, Tentler D, Kretz C, Dahl N, Mandel JL: Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human. Hum Mol Genet. 1998, 7: 1703-1712. 10.1093/hmg/7.11.1703.PubMed

116.

Cui X, De VI, Slany R, Miyamoto A, Firestein R, Cleary ML: Association of SET domain and myotubularin-related proteins modulates growth control. Nat Genet. 1998, 18: 331-337. 10.1038/ng0498-331.PubMed

117.

Blondeau F, Laporte J, Bodin S, Superti-Furga , Payrastre B, Mandel JL: Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum Mol Genet. 2000, 9 (15): 2223-2229.PubMed

118.

Taylor GS, Maehama T, Dixon JE: Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc Natl Acad Sci USA. 2000, 97: 8910-8915. 10.1073/pnas.160255697.PubMedCentralPubMed

119.

Chaussade C, Pirola L, Bonnafous S, Blondeau F, Brenz-Verca S, Tronchère H, Portis F, Rusconi S, Payrastre B, Laporte J, Van Obberghen E: Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Mol Endocrinol. 2003, 17: 2448-2460. 10.1210/me.2003-0261.PubMed

120.

Tsujita K, Itoh T, Ijuin T, Yamamoto A, Shisheva A, Laporte J, Takenawa T: Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction. J Biol Chem. 2004, 279: 13817-13824. 10.1074/jbc.M312294200.PubMed

121.

Tronchère H, Laporte J, Pendariest C, Chaussade C, Liaubet L, Pirola L, Mandel JL, Payrastre B: Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. J Biol Chem. 2004, 279 (8): 7404-7312.

122.

Laporte J, Blondeau F, Buj-Bello A, Mandel JL: The myotubularin family: from genetic disease to phosphoinositide metabolism. Trends Genet. 2001, 17: 221-228. 10.1016/S0168-9525(01)02245-4.PubMed

123.

Nandurkar HH, Layton M, Laporte J, Selan C, Corcoran L, Caldwell KK, Mochizuki Y, Majerus PW, Mitchell CA: Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP. Proc Natl Acad Sci USA. 2003, 100: 8660-8665. 10.1073/pnas.1033097100.PubMedCentralPubMed

124.

Laporte J, Bedez F, Bolino A, Mandel JL: Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum Mol Genet. 2003, 12 (Spec No 2): R285-292. 10.1093/hmg/ddg273.PubMed

125.

Clague MJ, Lorenzo O: The myotubularin family of lipid phosphatases. Traffic. 2005, 6 (12): 1063-1069. 10.1111/j.1600-0854.2005.00338.x.PubMed

126.

Robinson FL, Dixon JE: Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol. 2006, 16 (8): 403-412. 10.1016/j.tcb.2006.06.001.PubMed

127.

Buj-Bello A, Laugel V, Messadeq N, Zahreddine H, Laporte J, Pellisier JF, Mandel JL: The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Natl Acad Sci USA. 2002, 99: 15060-15065. 10.1073/pnas.212498399.

128.

Noguchi S, Fujita M, Murayama K, Kurokawa R, Nishino : Gene expression analyses in X-linked myotubular myopathy. Neurology. 2005, 65 (5): 732-737. 10.1212/01.wnl.0000174625.67484.4d.PubMed

129.

Fabrizi GM, Ferrarini M, Cavallaro T, Cabrini I, Cerini R, Bertolasi L, Rizzuto N: Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. Neurology. 2007, 69 (3): 291-295. 10.1212/01.wnl.0000265820.51075.61.PubMed

130.

Bitoun M, Stojkovic T, Prudhon B, Maurage CA, Latour P, Vermersch P, Guicheney P: A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findings. Neuromuscul Disord. 2008, 18 (4): 334-338. 10.1016/j.nmd.2008.01.005.PubMed

131.

Unsworth KE, Mazurkiewicz P, Senf F, Zettl M, McNiven M, Way M, Holden DW: Dynamin is required for F-actin assembly and pedestal formation by enteropathogenic Escherichia coli (EPEC). Cell Microbiol. 2007, 9 (2): 438-449. 10.1111/j.1462-5822.2006.00801.x.PubMed

132.

Thompson HM, Cao H, Chen J, Euteneuer U, McNiven MA: Dynamin 2 binds gamma-tubulin and participates in centrosome cohesion. Nat Cell Biol. 2004, 6 (4): 335-342. 10.1038/ncb1112.PubMed

133.

Jones SM, Howell KE, Henley JR, Cao H, McNiven MA: Role of dynamin in the formation of transport vesicles from the trans-Golgi network. Science. 1998, 279 (5350): 573-577. 10.1126/science.279.5350.573.PubMed

134.

Butler MH, David C, Ochoa GC, Freyberg Z, Daniell L, Grabs D, Cremona O, De Camilli P: Amphiphysin II (SH3P9; BIN1), a member of the amphiphysin/Rvs family, is concentrated in the cortical cytomatrix of axon initial segments and nodes of ranvier in brain and around T tubules in skeletal muscle. J Cell Biol. 1997, 137 (6): 1355-1367. 10.1083/jcb.137.6.1355.PubMedCentralPubMed

135.

Ramjaun AR, Micheva KD, Bouchelet I, McPherson PS: Identification and characterization of a nerve terminal-enriched amphiphysin isoform. J Biol Chem. 1997, 272 (26): 16700-16706. 10.1074/jbc.272.26.16700.PubMed

136.

Peter BJ, Kent HM, Mills IG, Vallis Y, Butler PJ, Evans PR, McMahon HT: BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science. 2004, 303 (5657): 495-499. 10.1126/science.1092586.PubMed

137.

Razzaq A, Robinson IM, McMahon HT, Skepper JN, Su Y, Zelhof AC, Jackson AP, Gay NJ, O'Kane CJ: Amphiphysin is necessary for organization of the excitation-contraction coupling machinery of muscles, but not for synaptic vesicle endocytosis in Drosophila. Genes Dev. 2001, 15 (22): 2967-2979. 10.1101/gad.207801.PubMedCentralPubMed

138.

Owen DJ, Wigge P, Vallis Y, Moore JD, Evans PR, McMahon HT: Crystal structure of the amphiphysin-2 SH3 domain and its role in the prevention of dynamin ring formation. EMBO J. 1998, 17 (18): 5273-5285. 10.1093/emboj/17.18.5273.PubMedCentralPubMed

139.

Lee E, Marcucci M, Daniell L, Pypaert M, Weisz OA, Ochoa GC, Farsad K, Wenk MR, De Camilli P: Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science. 2002, 297 (5584): 1193-1196. 10.1126/science.1071362.PubMed

140.

Tosch V, Rohde HM, Tronchère H, Zanoteli E, Monroy N, Kretz C, Dondaine N, Payrastre B, Mandel JL, Laporte J: A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. Hum Mol Genet. 2006, 15 (21): 3098-3106. 10.1093/hmg/ddl250.PubMed

141.

Bergen BJ, Carry MP, Wilson WB, Barden MT, Ringel SP: Centronuclear myopathy: extraocular and limb muscle findings in an adult. Muscle Nerve. 1980, 3: 165-171. 10.1002/mus.880030210.PubMed

142.

Sasaki T, Shikura K, Sugai K, Nonaka I, Kumagai K: Muscle histochemistry in myotubular (centronuclear) myopathy. Brain Dev. 1989, 11: 26-32.PubMed

143.

Danon MJ, Giometti CS, Manaligod JR, Swisher C: Sequential muscle biopsy changes in a case of congenital myopathy. Muscle Nerve. 1997, 20: 561-569. 10.1002/(SICI)1097-4598(199705)20:5<561::AID-MUS4>3.0.CO;2-7.PubMed

144.

Goebel HH, Meinck HM, Reinecke M, Schimrigk K, Mielke U: Centronuclear myopathy with special consideration of the adult form. Eur Neurol. 1984, 23: 425-434. 10.1159/000115725.PubMed

145.

Ven van der PF, Jap PH, Wetzels RH, ter Laak HJ, Ramaekers FC, Stadhouders AM, Sengers RC: Postnatal centralization of muscle fibre nuclei in centronuclear myopathy. Neuromuscul Disord. 1991, 1: 211-220. 10.1016/0960-8966(91)90027-P.PubMed

146.

Fidzianska A, Goebel HH: Aberrant arrested in maturation neuromuscular junctions in centronuclear myopathy. J Neurol Sci. 1994, 124: 83-88. 10.1016/0022-510X(94)90015-9.PubMed

147.

Ven van der F, Jap PH, ter Laak HJ, Nonaka I, Barth PG, Sengers RC, Stadhouders AM, Ramaekers FC: Immunophenotyping of congenital myopathies: disorganization of sarcomeric, cytoskeletal and extracellular matrix proteins. J Neurol Sci. 1995, 129: 199-213. 10.1016/0022-510X(94)00282-S.PubMed

148.

Sarnat HB: Myotubular myopathy: arrest of morphogenesis of myofibres associated with persistence of fetal vimentin and desmin. Four cases compared with fetal and neonatal muscle. Can J Neurol Sci. 1990, 17: 109-123.PubMed

149.

Sarnat HB: Vimentin and desmin in maturing skeletal muscle and developmental myopathies. Neurology. 1992, 42: 1616-1624.PubMed

150.

Sewry CA: The role of immunocytochemistry in congenital myopathies. Neuromuscular Disorders. 1998, 8: 394-400. 10.1016/S0960-8966(98)00053-4.PubMed

151.

Jungbluth H, Davis MR, Müller C, Counsell S, Allsop J, Chattopadhyay A, Messina S, Mercuri E, Laing NG, Sewry CA, Bydder G, Muntoni F: Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul Disord. 2004, 14 (12): 785-790. 10.1016/j.nmd.2004.08.006.PubMed

152.

Pénisson-Besnier I, Biancalana V, Reynier P, Cossée M, Dubas F: Diagnosis of myotubular myopathy in the oldest known manifesting female carrier: a clinical and genetic study. Neuromuscul Disord. 2007, 17 (2): 180-185. 10.1016/j.nmd.2006.10.008.PubMed

153.

Laporte J, Kress W, Mandel J: Diagnosis of X-linked myotubular myopathy by detection of myotubularin. Ann Neurol. 2001, 50: 42-46. 10.1002/ana.1033.PubMed

154.

Dubowitz V: Myotubular myopathy (centronuclear myopathy). Dubowitz V: Muscle biopsy – A practical approach. 1985, Baillière Tindall, 443-459. 2

155.

Hawkes CH, Absolon MJ: Myotubular myopathy associated with cataract and electrical myotonia. J Neurol Neurosurg Psychiatry. 1975, 38: 761-764.PubMedCentralPubMed

156.

Hulsmann N, Gullotta F, Okur H: Cytopathology of an unusual case of centronuclear myopathy. L. J Neurol Sci. 1981, 50: 311-333. 10.1016/0022-510X(81)90146-5.PubMed

157.

Wallgren-Pettersson C, Bushby K, Mellies U, Simonds A: 117^th ENMC workshop: Ventilatory Support in Congenital Neuromuscular Disorders: Congenital Myopathies, Congenital Muscular Dystrophies, Congenital Myotonic Dystrophy and SMA (II). April 4–6^th Naarden, the Netherlands. Neuromuscul Disord. 2003, 14: 56-69. 10.1016/j.nmd.2003.09.003.

158.

Howard RS, Wiles CM, Hirsch NP, Spencer GT: Respiratory involvement in primary muscle disorders: assessment and management. Q J Med. 1993, 86: 175-189.PubMed

159.

Akiyama C, Nonaka I: A follow-up study of congenital non-progressive myopathies. Brain Dev. 1996, 18: 404-408. 10.1016/0387-7604(96)00042-3.PubMed

160.

Hagberg UJM, Carroll JE, Brooke MH: Endurance exercise training in a patient with central core disease. Neurology. 1980, 30: 1242-1244.PubMed

161.

Denborough MA, Ebeling P, King JO, Zapf P: Myopathy and malignant hyperpyrexia. Lancet. 1970, 1 (7657): 1138-1140. 10.1016/S0140-6736(70)91215-8.PubMed

162.

Denborough MA, Dennett X, Anderson RM: Central-core disease and malignant hyperpyrexia. Br Med J. 1973, 1: 272-273.PubMedCentralPubMed

Title: Centronuclear (myotubular) myopathy
Authors: Heinz Jungbluth
Carina Wallgren-Pettersson
Jocelyn Laporte
Publication date: 01-12-2008
Publisher: BioMed Central
Published in: Orphanet Journal of Rare Diseases / Issue 1/2008
Electronic ISSN: 1750-1172
DOI: https://doi.org/10.1186/1750-1172-3-26

ACC 2024 Congress

Springer Medicine

Centronuclear (myotubular) myopathy

Abstract

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2008

Primary biliary cirrhosis

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia?

Mixed cryoglobulinemia

Malignant mesothelioma

Primary intestinal lymphangiectasia (Waldmann's disease)